Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Review

Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy

         
Total article views   Abstract views HTML views PDF downloads Totals
5,635 Dovepress* 2,468 1,244+ 1,029 3,712
PubMed Central* 0 1,923 302 1,923
Totals 2,468 3,167 1,331 5,635
*Since 11 April 2019
+Since July 2016

View citations on PubMed Central and Google Scholar